The open offer to acquire over 44,560,177 (4.45 crore) equity shares constituting 26% stake of Camlin Fine Sciences augurs well for the company, brokerage firm Axis Securities said, recommending a ‘buy’ on the stock.
from Economic Times https://ift.tt/NJZDIKC
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivi...
No comments:
Post a Comment